SENTINEL ONCOLOGY LTD has a total of 81 patent applications. It increased the IP activity by 300.0%. Its first patent ever was published in 2005. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are REGENACY PHARMACEUTICALS LLC, Orion Ophthalmology LLC and CAPELLA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 34 | |
#2 | WIPO (World Intellectual Property Organization) | 13 | |
#3 | EPO (European Patent Office) | 12 | |
#4 | United States | 10 | |
#5 | China | 4 | |
#6 | Australia | 2 | |
#7 | Brazil | 1 | |
#8 | Canada | 1 | |
#9 | Chile | 1 | |
#10 | Israel | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Boyle Robert George | 41 |
#2 | Walker David Winter | 30 |
#3 | Boyce Richard Justin | 14 |
#4 | Travers Stuart | 10 |
#5 | Farouz Francine | 3 |
#6 | Vo Cong Hung | 3 |
#7 | Peterson Scott | 3 |
#8 | Major Meriel Ruth | 2 |
#9 | Boyle Bob | 2 |
#10 | David Winter Walker | 2 |
Publication | Filing date | Title |
---|---|---|
GB202015187D0 | A pharmaceutical salt | |
GB202003646D0 | Pharmaceutical compounds | |
GB201914910D0 | Pharmaceutical compounds | |
GB201913921D0 | Pharmaceutical compounds | |
GB201706806D0 | Pharmaceutical compounds | |
KR20180061318A | 2-aminoquinazoline derivatives as P70S6 kinase inhibitors | |
GB201614037D0 | Pharmaceutical compounds | |
GB201517451D0 | Pharmaceutical compounds | |
GB201506933D0 | Pharmaceutical compounds | |
GB201502567D0 | Pharmaceutical compounds | |
GB201402277D0 | Pharmaceutical compounds | |
GB201402278D0 | Pharmaceutical compounds | |
GB201308780D0 | Pharmaceutical compounds | |
GB201308782D0 | Pharmaceutical compounds | |
GB201308781D0 | Pharmaceutical compounds | |
GB201209458D0 | Novel compounds and their use as kinase inhibitors | |
GB201206048D0 | Novel compounds and their use as kinase inhibitors | |
GB201119799D0 | Pharmaceutical compounds | |
GB201119796D0 | Pharmaceutical comopounds | |
GB201020366D0 | Pharmaceutical compounds |